Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance-Reference-Cited by-同舟云学术

Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance

Published:2015-01 Issue: Volume:198 Page:1-9
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Yhee Ji Young,Song Seungyong,Lee So Jin,Park Sung-Gurl,Kim Ki-Suk,Kim Myung Goo,Son Sejin,Koo Heebeom,Kwon Ick Chan,Jeong Ji Hoon,Jeong Seo Young,Kim Sun Hwa,Kim Kwangmeyung

Funder

National Research Foundation of Korea

MOTIE, Korea

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference35 articles.

1. Recent attempts at RNAi-mediated P-glycoprotein downregulation for reversal of multidrug resistance in cancer;Abbasi;Med. Res. Rev.,2013

2. The emergence of drug transporter-mediated multidrug resistance to cancer chemotherapy;Wu;Mol. Pharm.,2011

3. P-glycoprotein, multidrug resistance and tumor progression;Bradley;Cancer Metastasis Rev.,1994

4. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil;Tsuruo;Cancer Res.,1981

5. Drugs as P-glycoprotein substrates, inhibitors, and inducers;Kim;Drug Metab. Rev.,2002

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chitosan-based smart stimuli-responsive nanoparticles for gene delivery and gene therapy: Recent progresses on cancer therapy;International Journal of Biological Macromolecules;2024-10

2. Smart Physicochemical-triggered Chitosan-based Nanogels for siRNA Delivery and Gene Therapy: A Focus on Emerging Strategies and Paradigms for Cancer Therapy;Current Medicinal Chemistry;2024-06-05

3. Recent Advances in Engineering Carriers for siRNA Delivery;Macromolecular Bioscience;2024-01-12

4. Chitosan-functionalized bioplatforms and hydrogels in breast cancer: immunotherapy, phototherapy and clinical perspectives;Drug Discovery Today;2024-01

5. Fabrication of D-α-tocopheryl polyethylene glycol 1000 succinates and human serum albumin conjugated chitosan nanoparticles of bosutinib for colon targeting application; in vitro-in vivo investigation;International Journal of Biological Macromolecules;2023-12